These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1456384)

  • 1. A comparative clinical and pharmacokinetic study of a new slow-release versus conventional preparations of valproic acid in children with intractable epilepsy.
    Imaizumi T; Izumi T; Fukuyama Y
    Brain Dev; 1992 Sep; 14(5):304-8. PubMed ID: 1456384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conventional and controlled release valproate in children with epilepsy: a cross-over study comparing plasma levels and cognitive performances.
    Brouwer OF; Pieters MS; Edelbroek PM; Bakker AM; van Geel AA; Stijnen T; Jennekens-Schinkel A; Lanser JB; Peters AC
    Epilepsy Res; 1992 Dec; 13(3):245-53. PubMed ID: 1493787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conventional and sustained-release valproate in children with newly diagnosed epilepsy: a randomized and crossover study comparing clinical effects, patient preference and pharmacokinetics.
    Herranz JL; Arteaga R; Adín J; Armijo JA
    Eur J Clin Pharmacol; 2006 Oct; 62(10):805-15. PubMed ID: 16896786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A clinicopharmacological study of serum sodium valproate free level in children with epilepsy].
    Furuya M; Hashimoto K; Kamayachi S; Fujino O
    Nihon Ika Daigaku Zasshi; 1990 Dec; 57(6):513-23. PubMed ID: 2286644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free valproic acid: steady-state pharmacokinetics in patients with intractable epilepsy.
    Otten N; Hall K; Irvine-Meek J; Leroux M; Budnik D; Seshia S
    Can J Neurol Sci; 1984 Nov; 11(4):457-60. PubMed ID: 6440705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms and valproic acid plasma concentration in children with epilepsy on valproic acid monotherapy.
    Mei S; Feng W; Zhu L; Yu Y; Yang W; Gao B; Wu X; Zhao Z; Fang F
    Seizure; 2017 Oct; 51():22-26. PubMed ID: 28763744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Every-12-hour administration of extended-release divalproex in patients with epilepsy: impact on plasma valproic acid concentrations.
    Reed RC; Dutta S; Cavanaugh JH; Locke C; Granneman GR
    Epilepsy Behav; 2006 Mar; 8(2):391-6. PubMed ID: 16473558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic parameters of total and unbound valproic acid and their relationships to seizure control in epileptic children.
    Panomvana Na Ayudhya D; Suwanmanee J; Visudtibhan A
    Am J Ther; 2006; 13(3):211-7. PubMed ID: 16772762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and pharmacokinetic observations on sodium valproate - a 5-year follow-up study in 100 children with epilepsy.
    Henriksen O; Johannessen SI
    Acta Neurol Scand; 1982 May; 65(5):504-23. PubMed ID: 6810648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproic acid clearance in children with epilepsy.
    Sánchez-Alcaraz A; Quintana MB; López E; Rodríguez I
    J Clin Pharm Ther; 1998 Feb; 23(1):31-4. PubMed ID: 9756109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A population pharmacokinetic model of valproic acid in pediatric patients with epilepsy: a non-linear pharmacokinetic model based on protein-binding saturation.
    Ding J; Wang Y; Lin W; Wang C; Zhao L; Li X; Zhao Z; Miao L; Jiao Z
    Clin Pharmacokinet; 2015 Mar; 54(3):305-17. PubMed ID: 25388986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the pharmacokinetics of total and free valproate in mono- and bitherapy with carbamazepine in epileptic children and adolescents.
    Steinborn B; Galas-Zgorzalewicz B
    Folia Neuropathol; 2002; 40(2):97-100. PubMed ID: 12230261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological interaction between valproic acid and carbapenem: what about levels in pediatrics?
    Miranda Herrero MC; Alcaraz Romero AJ; Escudero Vilaplana V; Fernández Lafever SN; Fernández-Llamazares CM; Barredo Valderrama E; Vázquez López M; de Castro P
    Eur J Paediatr Neurol; 2015 Mar; 19(2):155-61. PubMed ID: 25578527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A population pharmacokinetic model taking into account protein binding for the sustained-release granule formulation of valproic acid in children with epilepsy.
    Rodrigues C; Chhun S; Chiron C; Dulac O; Rey E; Pons G; Jullien V
    Eur J Clin Pharmacol; 2018 Jun; 74(6):793-803. PubMed ID: 29564480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of childhood epilepsy with rectal valproate: case reports and pharmacokinetic study.
    Kanazawa O; Sengoku A; Kawai I
    Brain Dev; 1987; 9(6):615-20. PubMed ID: 3128135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of UGT1A6 and GABRA1 on Standardized Valproic Acid Plasma Concentrations and Treatment Effect in Children With Epilepsy in China.
    Feng W; Mei S; Zhu L; Yu Y; Yang W; Gao B; Wu X; Zhao Z; Fang F
    Ther Drug Monit; 2016 Dec; 38(6):738-743. PubMed ID: 27855134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion from delayed-release sodium valproate to extended-release sodium valproate: initial results and long-term follow-up.
    McCabe PH; Michel NC; McNew CD; Lehman EB
    Epilepsy Behav; 2006 May; 8(3):601-5. PubMed ID: 16678766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproate monotherapy in 30 patients with partial seizures.
    Dean JC; Penry JK
    Epilepsia; 1988; 29(2):140-4. PubMed ID: 3127196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of age and co-medication on the steady-state pharmacokinetics of valproic acid in Tunisian patients with epilepsy.
    Ben Mahmoud L; Hakim A; Ghozzi H; Atheymen R; Sahnoun Z; Zeghal K
    Rev Neurol (Paris); 2017 Mar; 173(3):159-163. PubMed ID: 28320517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Once-daily dosing is appropriate for extended-release divalproex over a wide dose range, but not for enteric-coated, delayed-release divalproex: evidence via computer simulations and implications for epilepsy therapy.
    Reed RC; Dutta S; Liu W
    Epilepsy Res; 2009 Dec; 87(2-3):260-7. PubMed ID: 19892524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.